Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)

NCT02573493 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of the Head and Neck
Carcinoma, Squamous Cell of the Head and Neck
Cancer of Head and Neck
Cancer of the Head and Neck
Head and Neck Cancer
Neoplasms, Head and Neck

Interventions

DRUG: nab-Paclitaxel
DRUG: Cisplatin
BIOLOGICAL: Cetuximab
RADIATION: Intensity-Modulated Radiation Therapy

Sponsor

Washington University School of Medicine

Collaborators

[object Object]